Microdosing Tirzepatide offers a gentler ramp-up that supports long-term compliance, preserves patient comfort, and allows for adjustments based on real-world results
For weight management or more pronounced glucose control, the dose may be gradually increased to 1.0 mg or higher over several weeks
These services require more legwork on your end, but theyll also teach you more about what your body needs
Across SELECT, STEPlike trials, pediatric obesity studies, and ESSENCE, Wegovy demonstrates robust, durable weight loss, clinically meaningful CV risk reduction, and promising liver histologic responses, albeit with an established GIdominant tolerability profile and specific but manageable safety concerns